2m 2m 2m 2m 2m 2m 2m
NEUROPACE (NPCE)
NASDAQ
$12.69-$0.46 (-3.50%)
Price as of Oct 02, 2026 5:07 PM EDT- $451.4MMarket Cap
- 26.08%1-Year Change
- Medical DevicesIndustry
NEUROPACE (NPCE)
$12.69-$0.46 (-3.50%)
NPCE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $13.15 | ||
Change | -$0.61 (-4.43%) | ||
Open | $13.81 | ||
High | $13.81 | ||
Low | $13.05 | ||
Previous Close | $13.76 | ||
Volume | 197,402 | ||
30-Day Average Volume | 133,935 | ||
1-Week Change | -5.87% | ||
1-Month Change | -10.79% | ||
1-Year Change | 26.08% | ||
3-Year Change | 35.15% | ||
5-Year Change | -16.77% | ||
Fundamentals | |||
Shares Outstanding | 34.3M | ||
Total Assets | $97.0M | ||
Market Cap | $451.4M | ||
Enterprise Value | $497.8M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$6.2M | ||
Free Cash Flow | -$4.0M | ||
EBIT | -$4.7M | ||
EBITDA | -$4.6M | ||
Net Working Capital | $68.8M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -107 | ||
Enterprise Value/Revenue | 22 | ||
P/B | 38 | ||
P/E | -73 | ||
PEG | -7 | ||
Price/Free Cash Flow | -112 | ||
Price/Operating Cash Flow | -116 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue